TFBS Bioscience Inc. (6939.TWO)

TWD 32.3

(1.1%)

Net Debt Summary of TFBS Bioscience Inc.

  • TFBS Bioscience Inc.'s latest annual net debt in 2023 was -797.57 Million TWD , up 13.71% from previous year.
  • TFBS Bioscience Inc.'s latest quarterly net debt in 2023 FY was -797.57 Million TWD , up 13.71% from previous quarter.
  • TFBS Bioscience Inc. reported annual net debt of -924.24 Million TWD in 2022, down -320.96% from previous year.
  • TFBS Bioscience Inc. reported annual net debt of -219.55 Million TWD in 2021, down -288.85% from previous year.
  • TFBS Bioscience Inc. reported quarterly net debt of -797.57 Million TWD for 2023 Q4, up 14.74% from previous quarter.
  • TFBS Bioscience Inc. reported quarterly net debt of -935.48 Million TWD for 2023 Q2, down -1.22% from previous quarter.

Annual Net Debt Chart of TFBS Bioscience Inc. (2023 - 2020)

Historical Annual Net Debt of TFBS Bioscience Inc. (2023 - 2020)

Year Net Debt Net Debt Growth
2023 -797.57 Million TWD 13.71%
2022 -924.24 Million TWD -320.96%
2021 -219.55 Million TWD -288.85%
2020 -56.46 Million TWD 0.0%

Peer Net Debt Comparison of TFBS Bioscience Inc.

Name Net Debt Net Debt Difference
BIONET Corp. -193.47 Million TWD -312.229%
DIVA Laboratories, Ltd. -534.39 Million TWD -49.248%
Genetics Generation Advancement Corp. -79.18 Million TWD -907.253%
Welgene Biotech Co.,Ltd. -33.78 Million TWD -2260.871%
Puriblood Medical Co., Ltd. -65.84 Million TWD -1111.362%